832 related articles for article (PubMed ID: 15118208)
1. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
Singh B; Verma M; Verma K
Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and trends of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in Delhi blood donors: a hospital based study.
Pahuja S; Sharma M; Baitha B; Jain M
Jpn J Infect Dis; 2007 Nov; 60(6):389-91. PubMed ID: 18032841
[TBL] [Abstract][Full Text] [Related]
3. Infectious markers in blood donors of East Delhi: prevalence and trends.
Singh B; Kataria SP; Gupta R
Indian J Pathol Microbiol; 2004 Oct; 47(4):477-9. PubMed ID: 16295370
[TBL] [Abstract][Full Text] [Related]
4. Screening test accuracy among potential blood donors of HBsAg, anti-HBc and anti-HCV to detect hepatitis B and C virus infection in rural Cambodia and Vietnam.
Bjoerkvoll B; Viet L; Ol HS; Lan NT; Sothy S; Hoel H; Gutteberg T; Husebekk A; Larsen S; Husum H
Southeast Asian J Trop Med Public Health; 2010 Sep; 41(5):1127-35. PubMed ID: 21073033
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Inoue J; Ulaankhuu D; Okamoto H
Arch Virol; 2005 Dec; 150(12):2513-28. PubMed ID: 16012782
[TBL] [Abstract][Full Text] [Related]
6. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of transfusion transmitted infections in blood donors: an Indian experience.
Chandra T; Kumar A; Gupta A
Trop Doct; 2009 Jul; 39(3):152-4. PubMed ID: 19535750
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence of VHB and VHC serological markers among blood donors in the capital state of Veracruz, Mexico].
Valerio-Ureña J; Vásquez-Fernández F; Pérez-Sosa JA; Cortazar-Benitez LF; Chávez-Tapia NC; Ruvalcaba-Rojas OA; Torres-Medina V; Ocejo-Rodríguez A
Gac Med Mex; 2009; 145(3):183-7. PubMed ID: 19685823
[TBL] [Abstract][Full Text] [Related]
9. Relative safety of first-time volunteer and replacement donors in West Africa.
Allain JP; Sarkodie F; Asenso-Mensah K; Owusu-Ofori S
Transfusion; 2010 Feb; 50(2):340-3. PubMed ID: 19843284
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran.
Ghavanini AA; Sabri MR
East Mediterr Health J; 2000; 6(5-6):1114-6. PubMed ID: 12197336
[TBL] [Abstract][Full Text] [Related]
11. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
Sukriti ; Pati NT; Sethi A; Agrawal K; Agrawal K; Kumar GT; Kumar M; Kaanan AT; Sarin SK
J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of hepatitis B and hepatitis C virus infections in potential blood donors in rural Cambodia.
Ol HS; Bjoerkvoll B; Sothy S; Van Heng Y; Hoel H; Husebekk A; Gutteberg T; Larsen S; Husum H
Southeast Asian J Trop Med Public Health; 2009 Sep; 40(5):963-71. PubMed ID: 19842380
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Hepatitis B and C in the normal population and high risk groups in north Kerala.
Sandesh K; Varghese T; Harikumar R; Beena P; Sasidharan VP; Bindu CS; Tony J; Harish K; Sunilkumar K; Ramachandran TM
Trop Gastroenterol; 2006; 27(2):80-3. PubMed ID: 17089617
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of markers of transfusion transmissible diseases in voluntary and replacement blood donors.
Sharma RR; Cheema R; Vajpayee M; Rao U; Kumar S; Marwaha N; Agnihotri SK
Natl Med J India; 2004; 17(1):19-21. PubMed ID: 15115227
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of hepatitis B surface antigen and hepatitis C virus antibodies among blood donors in Alexandria, Egypt.
Wasfi OA; Sadek NA
East Mediterr Health J; 2011 Mar; 17(3):238-42. PubMed ID: 21735965
[TBL] [Abstract][Full Text] [Related]
16. Estimated risk of transmission of hepatitis C virus by blood transfusion.
Koerner K; Cardoso M; Dengler T; Kerowgan M; Kubanek B
Vox Sang; 1998; 74(4):213-6. PubMed ID: 9691400
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998-2001.
Bashawri LA; Fawaz NA; Ahmad MS; Qadi AA; Almawi WY
Clin Lab Haematol; 2004 Jun; 26(3):225-8. PubMed ID: 15163322
[TBL] [Abstract][Full Text] [Related]
18. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
Erhabor O; Ejele OA; Nwauche CA
Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of mandatory transmissible diseases screening in Indian blood donors.
Choudhury N; Ramesh V; Saraswat S; Naik S
Indian J Med Res; 1995 Jun; 101():229-32. PubMed ID: 7672831
[TBL] [Abstract][Full Text] [Related]
20. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
